These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 1544585
1. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group. Petrovitch H, Vogt TM, Berge KG. Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585 [Abstract] [Full Text] [Related]
2. Stroke in the elderly treated for systolic hypertension (SHEP). Singer RB. J Insur Med; 1991 Mar; 23(4):265-9. PubMed ID: 10148513 [No Abstract] [Full Text] [Related]
3. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J. JAMA; 1996 Dec 18; 276(23):1886-92. PubMed ID: 8968014 [Abstract] [Full Text] [Related]
4. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA; 1991 Jun 26; 265(24):3255-64. PubMed ID: 2046107 [Abstract] [Full Text] [Related]
5. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials. Staessen J, Fagard R, Amery A. J Hum Hypertens; 1991 Dec 26; 5(6):469-74. PubMed ID: 1791605 [Abstract] [Full Text] [Related]
6. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM. Arch Intern Med; 1994 Oct 10; 154(19):2154-60. PubMed ID: 7944835 [Abstract] [Full Text] [Related]
8. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group. Hypertension; 1993 Mar 10; 21(3):335-43. PubMed ID: 8478043 [Abstract] [Full Text] [Related]
9. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB. Clin Exp Hypertens A; 1989 Mar 10; 11(5-6):973-89. PubMed ID: 2676266 [Abstract] [Full Text] [Related]
10. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP). Kostis JB, Berge KG, Davis BR, Hawkins CM, Probstfield J. Am J Hypertens; 1995 Dec 10; 8(12 Pt 1):1147-53. PubMed ID: 8998247 [Abstract] [Full Text] [Related]
11. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. Kostis JB, Davis BR, Cutler J, Grimm RH, Berge KG, Cohen JD, Lacy CR, Perry HM, Blaufox MD, Wassertheil-Smoller S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB. JAMA; 1997 Jul 16; 278(3):212-6. PubMed ID: 9218667 [Abstract] [Full Text] [Related]
12. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments]. Ménard J, Chatellier G. Presse Med; 1992 Nov 07; 21(37):1762-7. PubMed ID: 1362612 [Abstract] [Full Text] [Related]
13. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systoloc Hypertension in the elderly). Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R, Kostis J, Pressel S, Schron E. Arch Intern Med; 1996 Mar 11; 156(5):553-61. PubMed ID: 8604962 [Abstract] [Full Text] [Related]
14. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP). Perry HM, Davis BR, Price TR, Applegate WB, Fields WS, Guralnik JM, Kuller L, Pressel S, Stamler J, Probstfield JL. JAMA; 2000 Jul 26; 284(4):465-71. PubMed ID: 10904510 [Abstract] [Full Text] [Related]
15. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. Davis BR, Vogt T, Frost PH, Burlando A, Cohen J, Wilson A, Brass LM, Frishman W, Price T, Stamler J. Stroke; 1998 Jul 26; 29(7):1333-40. PubMed ID: 9660383 [Abstract] [Full Text] [Related]
16. Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality. Singer RB. J Insur Med; 1992 Jul 26; 24(1):28-31. PubMed ID: 10148474 [No Abstract] [Full Text] [Related]
17. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]. Oparil S, Bakir SE. Drugs; 2000 Jul 26; 59 Spec No 2():25-37. PubMed ID: 11002856 [Abstract] [Full Text] [Related]
18. Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U, ALLHAT Collaborative Research Group. Arch Intern Med; 2005 Jun 27; 165(12):1401-9. PubMed ID: 15983290 [Abstract] [Full Text] [Related]
19. Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): morbidity and mortality experience. Perry HM, McDonald RH, Hulley SB, Smith WM, Furberg CD, Greenlick MR, Kuller LH, Schnaper HW, Schoenberger JA, Vogt TM. J Hypertens Suppl; 1986 Dec 27; 4(6):S21-3. PubMed ID: 3302150 [Abstract] [Full Text] [Related]
20. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, Goff D, Leenen F, Mohiuddin S, Papademetriou V, Proschan M, Ellsworth A, Golden J, Colon P, Crow R, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Circulation; 2006 May 09; 113(18):2201-10. PubMed ID: 16651474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]